Correlation Between Adaptimmune Therapeutics and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Adaptimmune Therapeutics and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and ArriVent BioPharma,.
Diversification Opportunities for Adaptimmune Therapeutics and ArriVent BioPharma,
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Adaptimmune and ArriVent is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and ArriVent BioPharma,
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 0.89 times more return on investment than ArriVent BioPharma,. However, Adaptimmune Therapeutics Plc is 1.12 times less risky than ArriVent BioPharma,. It trades about 0.03 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.22 per unit of risk. If you would invest 58.00 in Adaptimmune Therapeutics Plc on November 28, 2024 and sell it today you would earn a total of 0.70 from holding Adaptimmune Therapeutics Plc or generate 1.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| ArriVent BioPharma, |
Adaptimmune Therapeutics and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and ArriVent BioPharma,
The main advantage of trading using opposite Adaptimmune Therapeutics and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.The idea behind Adaptimmune Therapeutics Plc and ArriVent BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| ArriVent BioPharma, vs. Yuexiu Transport Infrastructure | ArriVent BioPharma, vs. Rambler Metals and | ArriVent BioPharma, vs. Pearson PLC ADR | ArriVent BioPharma, vs. Afya |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |